Systemic Lupus Erythematosus Presented with Bilateral Orbital Edema and Negative Serology
Identifieur interne : 000278 ( Pmc/Corpus ); précédent : 000277; suivant : 000279Systemic Lupus Erythematosus Presented with Bilateral Orbital Edema and Negative Serology
Auteurs : Manal Al-Khaldi ; Manal AlsabbaghSource :
- Case Reports in Rheumatology [ 2090-6889 ] ; 2019.
Abstract
Isolated bilateral periorbital edema with negative serology is an extremely rare presentation of cutaneous lupus erythematosus that may lead to eyelid scarring, infection, or even corneal involvement. The treatment usually comprises a combination of hydroxychloroquine and a tapering dose of systemic steroids. Patients require long-term follow-up as they may develop systemic lupus erythematosus with positive serology later in life. We report a case of a 32-year-old female who presented with chronic bilateral periorbital edema, and the histopathology confirmed cutaneous lupus erythematosus.
Url:
DOI: 10.1155/2019/7140534
PubMed: 31662937
PubMed Central: 6778949
Links to Exploration step
PMC:6778949Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Systemic Lupus Erythematosus Presented with Bilateral Orbital Edema and Negative Serology</title><author><name sortKey="Al Khaldi, Manal" sort="Al Khaldi, Manal" uniqKey="Al Khaldi M" first="Manal" last="Al-Khaldi">Manal Al-Khaldi</name><affiliation><nlm:aff id="I1">Registrar, Internal Medicine Department, King Hamad University Hospital, AL-Muharraq, Bahrain</nlm:aff></affiliation></author><author><name sortKey="Alsabbagh, Manal" sort="Alsabbagh, Manal" uniqKey="Alsabbagh M" first="Manal" last="Alsabbagh">Manal Alsabbagh</name><affiliation><nlm:aff id="I2">Registrar, Internal Medicine Department, Dermatology, King Hamad University Hospital, AL-Muharraq, Bahrain</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">31662937</idno><idno type="pmc">6778949</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778949</idno><idno type="RBID">PMC:6778949</idno><idno type="doi">10.1155/2019/7140534</idno><date when="2019">2019</date><idno type="wicri:Area/Pmc/Corpus">000278</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000278</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Systemic Lupus Erythematosus Presented with Bilateral Orbital Edema and Negative Serology</title><author><name sortKey="Al Khaldi, Manal" sort="Al Khaldi, Manal" uniqKey="Al Khaldi M" first="Manal" last="Al-Khaldi">Manal Al-Khaldi</name><affiliation><nlm:aff id="I1">Registrar, Internal Medicine Department, King Hamad University Hospital, AL-Muharraq, Bahrain</nlm:aff></affiliation></author><author><name sortKey="Alsabbagh, Manal" sort="Alsabbagh, Manal" uniqKey="Alsabbagh M" first="Manal" last="Alsabbagh">Manal Alsabbagh</name><affiliation><nlm:aff id="I2">Registrar, Internal Medicine Department, Dermatology, King Hamad University Hospital, AL-Muharraq, Bahrain</nlm:aff></affiliation></author></analytic><series><title level="j">Case Reports in Rheumatology</title><idno type="ISSN">2090-6889</idno><idno type="eISSN">2090-6897</idno><imprint><date when="2019">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Isolated bilateral periorbital edema with negative serology is an extremely rare presentation of cutaneous lupus erythematosus that may lead to eyelid scarring, infection, or even corneal involvement. The treatment usually comprises a combination of hydroxychloroquine and a tapering dose of systemic steroids. Patients require long-term follow-up as they may develop systemic lupus erythematosus with positive serology later in life. We report a case of a 32-year-old female who presented with chronic bilateral periorbital edema, and the histopathology confirmed cutaneous lupus erythematosus.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Maidhof, W" uniqKey="Maidhof W">W. Maidhof</name></author><author><name sortKey="Hilas, O" uniqKey="Hilas O">O. Hilas</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Merola, J F" uniqKey="Merola J">J. F. Merola</name></author><author><name sortKey="Moschella, S L" uniqKey="Moschella S">S. L. Moschella</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lee, L A" uniqKey="Lee L">L. A. Lee</name></author><author><name sortKey="Werth, V P" uniqKey="Werth V">V. P. Werth</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Costner, M I" uniqKey="Costner M">M. I. Costner</name></author><author><name sortKey="Sontheimer, R D" uniqKey="Sontheimer R">R. D. Sontheimer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Erras, S" uniqKey="Erras S">S. Erras</name></author><author><name sortKey="Benjilali, L" uniqKey="Benjilali L">L. Benjilali</name></author><author><name sortKey="Essaadouni, L" uniqKey="Essaadouni L">L. Essaadouni</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Monji, K" uniqKey="Monji K">K. Monji</name></author><author><name sortKey="Yumiko, K" uniqKey="Yumiko K">K. Yumiko</name></author><author><name sortKey="Hiromaro, K" uniqKey="Hiromaro K">K. Hiromaro</name></author><author><name sortKey="Juichiro, N" uniqKey="Juichiro N">N. Juichiro</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Xiaomei, C" uniqKey="Xiaomei C">C. Xiaomei</name></author><author><name sortKey="Wang, S" uniqKey="Wang S">S. Wang</name></author><author><name sortKey="Li, L" uniqKey="Li L">L. Li</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Satoshi, N" uniqKey="Satoshi N">N. Satoshi</name></author><author><name sortKey="Yamada, T" uniqKey="Yamada T">T. Yamada</name></author><author><name sortKey="Umemoto, N" uniqKey="Umemoto N">N. Umemoto</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Acharya, N" uniqKey="Acharya N">N. Acharya</name></author><author><name sortKey="Pinedaii, R" uniqKey="Pinedaii R">R. Pinedaii</name></author><author><name sortKey="Uy, H" uniqKey="Uy H">H. Uy</name></author><author><name sortKey="Foster, C" uniqKey="Foster C">C. Foster</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gupta, T" uniqKey="Gupta T">T. Gupta</name></author><author><name sortKey="Beaconsfield, M" uniqKey="Beaconsfield M">M. Beaconsfield</name></author><author><name sortKey="Rose, G E" uniqKey="Rose G">G. E. Rose</name></author><author><name sortKey="Verity, D H" uniqKey="Verity D">D. H. Verity</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Trindade, M A B" uniqKey="Trindade M">M. A. B. Trindade</name></author><author><name sortKey="Alchorne, A O A" uniqKey="Alchorne A">A. O. A Alchorne</name></author><author><name sortKey="Da Costa, E B" uniqKey="Da Costa E">E. B. da Costa</name></author><author><name sortKey="Enokihara, M M S S" uniqKey="Enokihara M">M. M. S. S. Enokihara</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Serarslan, G" uniqKey="Serarslan G">G. Serarslan</name></author><author><name sortKey="Atik, E" uniqKey="Atik E">E. Atik</name></author><author><name sortKey="Sarikaya, G" uniqKey="Sarikaya G">G. Sarikaya</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kopaschilis, N" uniqKey="Kopaschilis N">N. Kopaschilis</name></author><author><name sortKey="Tsaousis, K T" uniqKey="Tsaousis K">K. T. Tsaousis</name></author><author><name sortKey="Tourtas, T" uniqKey="Tourtas T">T. Tourtas</name></author><author><name sortKey="Tsinopoulos, I T" uniqKey="Tsinopoulos I">I. T. Tsinopoulos</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="case-report"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Case Rep Rheumatol</journal-id><journal-id journal-id-type="iso-abbrev">Case Rep Rheumatol</journal-id><journal-id journal-id-type="publisher-id">CRIRH</journal-id><journal-title-group><journal-title>Case Reports in Rheumatology</journal-title></journal-title-group><issn pub-type="ppub">2090-6889</issn><issn pub-type="epub">2090-6897</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31662937</article-id><article-id pub-id-type="pmc">6778949</article-id><article-id pub-id-type="doi">10.1155/2019/7140534</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Systemic Lupus Erythematosus Presented with Bilateral Orbital Edema and Negative Serology</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7265-712X</contrib-id><name><surname>Al-Khaldi</surname><given-names>Manal</given-names></name><email>manalalkhaldi1000@hotmail.com</email><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Alsabbagh</surname><given-names>Manal</given-names></name><xref ref-type="aff" rid="I2"><sup>2</sup></xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Registrar, Internal Medicine Department, King Hamad University Hospital, AL-Muharraq, Bahrain</aff><aff id="I2"><sup>2</sup>Registrar, Internal Medicine Department, Dermatology, King Hamad University Hospital, AL-Muharraq, Bahrain</aff><author-notes><fn fn-type="other"><p>Academic Editor: Gregory J. Tsay</p></fn></author-notes><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>23</day><month>9</month><year>2019</year></pub-date><volume>2019</volume><elocation-id>7140534</elocation-id><history><date date-type="received"><day>7</day><month>4</month><year>2019</year></date><date date-type="rev-recd"><day>26</day><month>6</month><year>2019</year></date><date date-type="accepted"><day>21</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>Copyright © 2019 Manal Al-Khaldi and Manal Alsabbagh.</copyright-statement><copyright-year>2019</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Isolated bilateral periorbital edema with negative serology is an extremely rare presentation of cutaneous lupus erythematosus that may lead to eyelid scarring, infection, or even corneal involvement. The treatment usually comprises a combination of hydroxychloroquine and a tapering dose of systemic steroids. Patients require long-term follow-up as they may develop systemic lupus erythematosus with positive serology later in life. We report a case of a 32-year-old female who presented with chronic bilateral periorbital edema, and the histopathology confirmed cutaneous lupus erythematosus.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Lupus erythematous is a chronic inflammatory autoimmune disease which encompasses a wide range of clinical manifestations affecting multiple organ systems. There are four main types of lupus: neonatal lupus, discoid lupus, drug-induced lupus, and systemic lupus erythematosus [<xref rid="B1" ref-type="bibr">1</xref>]. The modified Gilliam grouping system is a modified classification for cutaneous lupus erythematosus which comprises acute cutaneous lupus erythematosus (ACLE), subacute cutaneous lupus erythematosus (SCLE), and chronic cutaneous lupus erythematosus (CLE) [<xref rid="B2" ref-type="bibr">2</xref>].</p><p>Clinically, each type of cutaneous lupus presents with some specific features. For instance, discoid lupus presents with thick, firm, erythematous, scaly, and well-demarcated plaques that have the potential to heal with scarring, alopecia, and hypopigmentation [<xref rid="B3" ref-type="bibr">3</xref>].</p><p>The presentation of eyelid edema is extremely rare; the reported incidence is 0.1% as for the presenting manifestation of systemic lupus erythematous with an overall incidence of 4.8% [<xref rid="B4" ref-type="bibr">4</xref>]. Diagnosis for these cases is essential to prevent scarring, and long-term follow-up is needed as 5% of the population has the risk of developing systemic lupus erythematosus.</p><p>In general, the key characteristic that unites cutaneous lupus erythematosus is the histopathology presentations of the following features: hyperkeratosis, epidermal atrophy, vacuolar interface dermatitis, perivascular, and perifollicular mononuclear cell inflammatory infiltrate, with or without the presence of civatte bodies and follicular plugging [<xref rid="B5" ref-type="bibr">5</xref>].</p></sec><sec id="sec2"><title>2. Case Presentation</title><p>A 32-year-old African female presented to the emergency department complaining of persisted periorbital swelling, joint pain, and fever. The periorbital swelling was initially noticed 3 months before her presentation with mild pruritus and no visual disturbance. In addition, she was having intermittent joint pain involving the wrists, fingers, and shoulders. The fever was subjective and not documented with any history of sweating.</p><p>On presentation, she also complained of a two-week history of sore throat and difficulty in breathing. Paracetamol was the only medicine the patient was taking to manage her symptoms. She denied using any new medication or product and denied any previous history of allergies.</p><p>On her arrival, her vitals were normal and stable. Clinical examination revealed bilateral erythematous periorbital edema with violaceous hue, right cervical lymphadenopathy, and mild friction rub on the lower zone of the right lung. She had tenderness of the wrists, proximal metacarpal joints, and shoulders; movement restriction due to pain was noticed. Cardiovascular, breast, and abdominal examinations were uneventful.</p><p>Electrocardiography showed a sinus rhythm with a regular rate and no abnormalities. A chest X-ray showed pleural thickening at the right lung base.</p><p>The patient was admitted to the internal medicine department for further investigations. Abdominal ultrasound was normal with no abdominal lymphadenopathy. CT chest with contrast showed right lateral pleurodiaphragmatic adhesions and fibrotic bands.</p><p>Laboratory investigations revealed mild lymphopenia, an elevated serum ferritin level, and a mildly elevated erythrocyte sedimentation rate (Tables <xref rid="tab1" ref-type="table">1</xref> and <xref rid="tab2" ref-type="table">2</xref>).</p><p>The echocardiogram showed a normal left ventricular cavity size with a preserved ventricular ejection fraction of 55%, and the systolic pulmonary artery pressure was 21 mmHg.</p><p>For this case, it was of interest to draw a list of differential diagnosis that includes sarcoidosis, Still's disease, systemic lupus erythematosus, rheumatoid arthritis, amyloidosis, chronic blepharitis, eczema, contact dermatitis, psoriasis, and lymphoma. Still's disease was brought to attention due to an elevated ferritin level; however, there was absence of the classic triad of persistent high-grade fever, joint pain, and a distinctive salmon-colored skin lesion.</p><p>Therefore, it remained unclear whether it was systemic lupus erythematosus or amyloidosis until skin biopsy from the eyelid was attempted, and the histopathology results showed degeneration with follicular plugging and dermal inflammatory cell infiltrate. These features were consistent with lupus erythematosus with skin involvement (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>The patient was started on prednisolone 40 mg orally once per day with noticeable improvement in periorbital edema and joint tenderness; however, unfortunately, the patient had presented once in the internal medicine clinic after her discharge, while the skin biopsy results were still pending and did not attend further appointments.</p></sec><sec id="sec3"><title>3. Discussion</title><p>Chronic bilateral periorbital edema that poorly responds to topical treatment should raise the suspicion of rare disorders, with possibility of neoplasm or connective tissue disease. Wu et al. reviewed 25 patients presented primarily with periorbital edema with a diagnosis of cutaneous lupus in addition to reviewing 10 cases from the literature. The majority of the patients were females (68%), and only four of the 25 patients had bilateral involvement. Seventy-two percent had their upper eyelid involved. Majority of the patients were misdiagnosed or suspected to have contact dermatitis, dermatomyositis, lymphoproliferative neoplasm, facial cellulitis, and severe angioedema. Our patient was a female with bilateral eyelid erythematous edema. The initial impression was of an allergic reaction and angioedema. Nineteen of the 25 patients as well as our patient had a negative ANA rate in that study (<xref rid="tab3" ref-type="table">Table 3</xref>).</p><p>There is a broad implication of shared histological features in lupus erythematosus; 80% of patients had basal cell vacuolar degeneration, 44% had lymphocytic infiltration, and 40% had follicular plugging. Those findings were consistent with our case.</p><p>Although our case showed features such as arthritis, pleuritic thickening, and initial lymphopenia, the serologic profile came negative. Wu et al. reported 6 patients, who initially presented with periorbital edema and developed systemic involvement, meeting the American College of Rheumatology criteria for diagnosing systemic lupus. Furthermore, Wu et al. found that 10 cases with lupus erythematosus were reported in the literature with primary presentation of periorbital erythematous edema. Of those, 9 were females, and 6 had a positive ANA. Similarly, cases were misdiagnosed as lymphoproliferative disease, blepharitis, and chalazion.</p></sec><sec id="sec4"><title>4. Conclusion</title><p>Isolated bilateral orbital edema is an extremely rare presentation and found possible to be presented before other skin lesions, the challenges with negative serology impact on diagnosis for cutaneous lupus erythematous, and therefore, these cases are treated as chronic eczema or angioedema. It is essential for patients presenting with eyelid lesions and who fail the treatment for eczema or infections to have a full careful skin examination and skin biopsy for diagnosis.</p></sec></body><back><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no conflicts of interest.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maidhof</surname><given-names>W.</given-names></name><name><surname>Hilas</surname><given-names>O.</given-names></name></person-group><article-title>Lupus: an overview of the disease and management options</article-title><source><italic toggle="yes">Physical Therapy</italic></source><year>2012</year><volume>37</volume><issue>4</issue><fpage>240</fpage><lpage>249</lpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Merola</surname><given-names>J. F.</given-names></name><name><surname>Moschella</surname><given-names>S. L.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Post</surname><given-names>T. W.</given-names></name></person-group><source><italic toggle="yes">UpToDate</italic></source><year>2019</year><publisher-loc>Waltham, MA, USA</publisher-loc><publisher-name>UpToDate</publisher-name></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>L. A.</given-names></name><name><surname>Werth</surname><given-names>V. P.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Bolognia</surname><given-names>J. L.</given-names></name><name><surname>Schaffer</surname><given-names>J. V.</given-names></name><name><surname>Cerroni</surname><given-names>L.</given-names></name></person-group><article-title>Lupus erythematosus</article-title><source><italic toggle="yes">Dermatology</italic></source><year>2018</year><volume>1</volume><edition>4th</edition><publisher-loc>Amsterdam, Netherlands</publisher-loc><publisher-name>Elsevier</publisher-name></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Costner</surname><given-names>M. I.</given-names></name><name><surname>Sontheimer</surname><given-names>R. D.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Goldsmith</surname><given-names>L. A.</given-names></name><name><surname>Katz</surname><given-names>S. I.</given-names></name><name><surname>Gilchrest</surname><given-names>B. A.</given-names></name><etal></etal></person-group><article-title>Lupus erythematosus</article-title><source><italic toggle="yes">Fitzpatrick’s Dermatology in General Medicine</italic></source><year>2012</year><volume>2</volume><edition>8th</edition><publisher-loc>New York, NY, USA</publisher-loc><publisher-name>McGraw-Hill</publisher-name></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erras</surname><given-names>S.</given-names></name><name><surname>Benjilali</surname><given-names>L.</given-names></name><name><surname>Essaadouni</surname><given-names>L.</given-names></name></person-group><article-title>Periorbital edema as initial manifestation of chronic cutaneous lupus erythematosus</article-title><source><italic toggle="yes">Pan African Medical Journal</italic></source><year>2012</year><volume>12</volume><fpage>p. 57</fpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monji</surname><given-names>K.</given-names></name><name><surname>Yumiko</surname><given-names>K.</given-names></name><name><surname>Hiromaro</surname><given-names>K.</given-names></name><name><surname>Juichiro</surname><given-names>N.</given-names></name></person-group><article-title>A case of discoid lupus erythematosus of the eyelid</article-title><source><italic toggle="yes">The Journal of Dermatology</italic></source><year>2006</year><volume>33</volume><issue>5</issue><fpage>368</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1111/j.1346-8138.2006.00087.x</pub-id><pub-id pub-id-type="other">2-s2.0-33745309414</pub-id><pub-id pub-id-type="pmid">16700672</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiaomei</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name></person-group><article-title>A case report of lupus erythematosus tumidus converted from discoid lupus erythematosus</article-title><source><italic toggle="yes">Medicine</italic></source><year>2018</year><volume>97</volume><issue>16</issue><pub-id pub-id-type="publisher-id">e0375</pub-id><pub-id pub-id-type="doi">10.1097/MD.0000000000010375</pub-id><pub-id pub-id-type="other">2-s2.0-85045862035</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoshi</surname><given-names>N.</given-names></name><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Umemoto</surname><given-names>N.</given-names></name></person-group><article-title>Cheek and periorbital peculiar discoid lupus erythematosus: rare clinical presentation mimicking tinea faciei, cutaneous gransulomatous disease or blepharitis</article-title><source><italic toggle="yes">Case Reports in Deramtology</italic></source><year>2015</year><volume>7</volume><issue>1</issue><fpage>56</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1159/000381208</pub-id><pub-id pub-id-type="other">2-s2.0-84929574991</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>N.</given-names></name><name><surname>Pinedaii</surname><given-names>R.</given-names></name><name><surname>Uy</surname><given-names>H.</given-names></name><name><surname>Foster</surname><given-names>C.</given-names></name></person-group><article-title>Discoid lupus erythematosus masquerading as chronic blepharoconjuctivitis</article-title><source><italic toggle="yes">Ophthalmology</italic></source><year>2005</year><volume>112</volume><issue>5</issue><fpage>e19</fpage><lpage>e23</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2005.01.035</pub-id><pub-id pub-id-type="other">2-s2.0-18244395308</pub-id><pub-id pub-id-type="pmid">15878050</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>T.</given-names></name><name><surname>Beaconsfield</surname><given-names>M.</given-names></name><name><surname>Rose</surname><given-names>G. E.</given-names></name><name><surname>Verity</surname><given-names>D. H.</given-names></name></person-group><article-title>Discoid lupus erythematosus of the periorbita:clinical dilemmas diagnostic delays</article-title><source><italic toggle="yes">Eye</italic></source><year>2012</year><volume>26</volume><issue>4</issue><fpage>609</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1038/eye.2011.340</pub-id><pub-id pub-id-type="other">2-s2.0-84859772176</pub-id><pub-id pub-id-type="pmid">22241018</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trindade</surname><given-names>M. A. B.</given-names></name><name><surname>Alchorne</surname><given-names>A. O. A</given-names></name><name><surname>da Costa</surname><given-names>E. B.</given-names></name><name><surname>Enokihara</surname><given-names>M. M. S. S.</given-names></name></person-group><article-title>Eyelid discoid lupus erythematosus and contact dermatitis: a case report</article-title><source><italic toggle="yes">Journal of the European Academy of Dermatology and Venereology</italic></source><year>2004</year><volume>18</volume><issue>5</issue><fpage>577</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1111/j.1468-3083.2004.00973.x</pub-id><pub-id pub-id-type="other">2-s2.0-4544303662</pub-id><pub-id pub-id-type="pmid">15324398</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serarslan</surname><given-names>G.</given-names></name><name><surname>Atik</surname><given-names>E.</given-names></name><name><surname>Sarikaya</surname><given-names>G.</given-names></name></person-group><article-title>Periorbital edema and erythema: an unusual localization of DLE in a patient with psoriasis</article-title><source><italic toggle="yes">The Journal of Dermatology</italic></source><year>2011</year><volume>38</volume><issue>5</issue><fpage>486</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1111/j.1346-8138.2010.01096.x</pub-id><pub-id pub-id-type="other">2-s2.0-79955473490</pub-id><pub-id pub-id-type="pmid">21352328</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopaschilis</surname><given-names>N.</given-names></name><name><surname>Tsaousis</surname><given-names>K. T.</given-names></name><name><surname>Tourtas</surname><given-names>T.</given-names></name><name><surname>Tsinopoulos</surname><given-names>I. T.</given-names></name></person-group><article-title>Severe chronic blepharitis and scarring ectropion associated with discoid lupus erythematosus</article-title><source><italic toggle="yes">Clinical and Experimental Optomerty</italic></source><year>2013</year><volume>96</volume><issue>1</issue><fpage>124</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1111/j.1444-0938.2012.00777.x</pub-id><pub-id pub-id-type="other">2-s2.0-84871929333</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Skin with focal basal cell damage and vacuolar degeneration. There is follicular plugging with a mild dermal inflammatory cell infiltrate. There is no evidence of malignancy. The features are consistent with cutaneous lupus.</p></caption><graphic xlink:href="CRIRH2019-7140534.001"></graphic></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Laboratory investigations.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">WBC</td><td align="center" rowspan="1" colspan="1">4.2 × 10<sup>9</sup>/L</td><td align="center" rowspan="1" colspan="1">ASO quantitative</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocytes</td><td align="center" rowspan="1" colspan="1">0.88 × 10<sup>9</sup>/L</td><td align="center" rowspan="1" colspan="1">Creatine kinase</td><td align="center" rowspan="1" colspan="1">110.6 u/l</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutrophil absolute</td><td align="center" rowspan="1" colspan="1">2.89 × 10<sup>9</sup>/L</td><td align="center" rowspan="1" colspan="1">Ferritin</td><td align="center" rowspan="1" colspan="1">1330 ng/ml</td></tr><tr><td align="left" rowspan="1" colspan="1">Monocyte absolute</td><td align="center" rowspan="1" colspan="1">0.28 × 10<sup>9</sup>/L</td><td align="center" rowspan="1" colspan="1">Serum iron</td><td align="center" rowspan="1" colspan="1">4.46 <italic>μ</italic>mol/L</td></tr><tr><td align="left" rowspan="1" colspan="1">Eosinophil absolute</td><td align="center" rowspan="1" colspan="1">0.15 × 10<sup>9</sup>/L</td><td align="center" rowspan="1" colspan="1">TIBC</td><td align="center" rowspan="1" colspan="1">34 <italic>μ</italic>mol/L</td></tr><tr><td align="left" rowspan="1" colspan="1">Basophil absolute</td><td align="center" rowspan="1" colspan="1">0.03 × 10<sup>9</sup>/L</td><td align="center" rowspan="1" colspan="1">Transferrin saturation</td><td align="center" rowspan="1" colspan="1">12.97%</td></tr><tr><td align="left" rowspan="1" colspan="1">HGB</td><td align="center" rowspan="1" colspan="1">12.5 g/dl</td><td align="center" rowspan="1" colspan="1">TFT</td><td align="center" rowspan="1" colspan="1">TSH 2.387 iu/ml<break></break>T4 1.09 ng/dl<break></break>T3 2.86 pn/ml</td></tr><tr><td align="left" rowspan="1" colspan="1">PLT</td><td align="center" rowspan="1" colspan="1">162 × 10<sup>9</sup>/L</td><td align="left" rowspan="1" colspan="1"> </td><td align="left" rowspan="1" colspan="1"> </td></tr><tr><td align="left" rowspan="1" colspan="1">Serum creatinine</td><td align="center" rowspan="1" colspan="1">82 mmol/L</td><td align="center" rowspan="1" colspan="1">ESR</td><td align="center" rowspan="1" colspan="1">48 mm/hr</td></tr><tr><td align="left" rowspan="1" colspan="1">Urea</td><td align="center" rowspan="1" colspan="1">7 mmol/L</td><td align="center" rowspan="1" colspan="1">CRP</td><td align="center" rowspan="1" colspan="1">6.5 mg/L</td></tr><tr><td align="left" rowspan="1" colspan="1">Na</td><td align="center" rowspan="1" colspan="1">141 mmol/L</td><td align="left" rowspan="1" colspan="1"> </td><td align="left" rowspan="1" colspan="1"> </td></tr><tr><td align="left" rowspan="1" colspan="1">K</td><td align="center" rowspan="1" colspan="1">4.6 mmol/L</td><td align="center" rowspan="1" colspan="1">24 h urine creatinine and volume 1300 ml</td><td align="center" rowspan="1" colspan="1">9.3 mmol/24 hrs.</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum albumin</td><td align="center" rowspan="1" colspan="1">32.5 g/l</td><td align="center" rowspan="1" colspan="1">24 h protein</td><td align="center" rowspan="1" colspan="1">0.21 gm/24 hrs.</td></tr><tr><td align="left" rowspan="1" colspan="1">Total bilirubin</td><td align="center" rowspan="1" colspan="1">5.57 <italic>μ</italic>mol/l</td><td align="left" rowspan="1" colspan="1"> </td><td align="left" rowspan="1" colspan="1"> </td></tr><tr><td align="left" rowspan="1" colspan="1">ALT</td><td align="center" rowspan="1" colspan="1">43 u/l</td><td align="center" rowspan="1" colspan="1">Urinalysis</td><td align="center" rowspan="1" colspan="1">Glucose 100 mg/dl, protein 30 mg/dl</td></tr><tr><td align="left" rowspan="1" colspan="1">AST</td><td align="center" rowspan="1" colspan="1">59 u/l</td><td align="left" rowspan="1" colspan="1"> </td><td align="left" rowspan="1" colspan="1"> </td></tr><tr><td align="left" rowspan="1" colspan="1">GGT</td><td align="center" rowspan="1" colspan="1">88.2 u/l</td><td align="center" rowspan="1" colspan="1">Throat swab for beta hemolytic streptococci</td><td align="center" rowspan="1" colspan="1">Negative</td></tr></tbody></table><table-wrap-foot><fn><p>WBC, white blood cell count; HBG, serum hemoglobin; PLT, platelets; Na, serum sodium; K, serum potassium; ALT, alanine transaminase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase; ASO, antistreptolysin O; TIBC, total iron-binding capacity; TSH, thyroid-stimulating hormone; TFT, thyroid function test; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Immunochemistry.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">ANA CTD screen</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">Anti-RNP70</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-CCP IgG</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">Anti-Jo1</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Antirheumatoid factor IgA</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">Anti-Scl-70</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Antirheumatoid factor IgM</td><td align="center" rowspan="1" colspan="1">1.1</td><td align="center" rowspan="1" colspan="1">Antismith</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Rheumatoid factor quantitative</td><td align="center" rowspan="1" colspan="1">9.12 iu/ml (<20)</td><td align="center" rowspan="1" colspan="1">Anti-SS-A/RO, Anti-SSB/LA</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Anticardiolipin IgG, IgM, and IgA</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">Anti-U1RNP</td><td align="center" rowspan="1" colspan="1">Negative</td></tr><tr><td align="left" rowspan="1" colspan="1">Lupus anticoagulant</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">C3</td><td align="center" rowspan="1" colspan="1">1.5 (normal range?)</td></tr><tr><td align="left" rowspan="1" colspan="1">Anticentromere protein B</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">C4</td><td align="center" rowspan="1" colspan="1">0.364 (normal range?)</td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-ds DNA</td><td align="center" rowspan="1" colspan="1">Negative</td><td align="center" rowspan="1" colspan="1">Vitamin D</td><td align="center" rowspan="1" colspan="1">11.5 ng/ml</td></tr><tr><td align="left" rowspan="1" colspan="1">ACE</td><td align="center" rowspan="1" colspan="1">Normal range</td><td align="center" rowspan="1" colspan="1"> </td><td align="left" rowspan="1" colspan="1"> </td></tr></tbody></table><table-wrap-foot><fn><p>ANA: antineutrophil antibody; CTD screen: connective tissue disease screen; anti-ds DNA: anti-double-stranded DNA; ACE: angiotensin-converting enzyme; anti-RNP70 antibody: anti-ribonucleoprotein antibody; anti-Jo1 antibody: myositis-specific autoantibodies directed against the histidyl-tRNA synthetase; anti-Scl-70: anti-topoisomerase antibody; anti-SSA/Ro autoantibodies: anti-Sjögren's-syndrome-related antigen A; anti-U1RNP: anti-ribonucleoprotein.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>A summary of similar presentations that found in different case reports.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Case</th><th align="center" rowspan="1" colspan="1">Date</th><th align="center" rowspan="1" colspan="1">Clinical presentation</th><th align="center" rowspan="1" colspan="1">Laboratory finding</th><th align="center" rowspan="1" colspan="1">Histopathology</th><th align="center" rowspan="1" colspan="1">Treatment</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">A case of discoid lupus erythematosus of the eyelid [<xref rid="B6" ref-type="bibr">6</xref>]</td><td align="center" rowspan="1" colspan="1">2006</td><td align="center" rowspan="1" colspan="1">A 39-year-old man presented with erosive erythema of the left lower eyelid</td><td align="center" rowspan="1" colspan="1">Antinuclear antibody,<break></break>anti-double-stranded (ds) DNA,<break></break>anti-Sm antibody,<break></break>anti-SS- A, and <break></break>anti-SS-B were all negative</td><td align="center" rowspan="1" colspan="1">A biopsy from the eyelid showed liquefaction and degeneration of the basal layer of the epidermis and the appendage epithelium. The finding is consistent with DLE.<break></break>The patient response to prednisolone</td><td align="center" rowspan="1" colspan="1">Prednisolone 10 mg/day, antiallergic drug (cetirizine hydrochloride), and betamethasone sodium phosphate eye drop for 2 years.<break></break>The skin lesion resolved over 8 months</td></tr><tr><td align="left" colspan="6" rowspan="1"><hr></hr></td></tr><tr><td align="left" rowspan="1" colspan="1">A case report of lupus erythematosus tumidus converted from discoid lupus erythematosus [<xref rid="B7" ref-type="bibr">7</xref>]</td><td align="center" rowspan="1" colspan="1">2018</td><td align="center" rowspan="1" colspan="1">A 62-year-old Chinese man presented with a one-year history of recurrent erythematous facial plaques and bilateral swelling of the eyelid</td><td align="center" rowspan="1" colspan="1">Antinuclear antibodies were positive. Anti-double-stranded DNA antibodies, anti-RO/SS-A, and anti-La/SS-B antibodies were all negative</td><td align="center" rowspan="1" colspan="1">Histopathology demonstrated liquefaction degeneration of basal cells and perivascular and periadnexal infiltration lymphocytes</td><td align="center" rowspan="1" colspan="1">Prednisolone 1 mg/kg/day combined with hydroxychloroquine 200 mg twice per day and topical tacrolimus.<break></break>The patient had complete recovery over 4 months with no relapse over 6 months</td></tr><tr><td align="left" colspan="6" rowspan="1"><hr></hr></td></tr><tr><td align="left" rowspan="1" colspan="1">Cheek and periorbital peculiar discoid lupus erythematosus: a rare clinical presentation mimicking tinea faciei cutaneous granulomatous disease or blepharitis [<xref rid="B8" ref-type="bibr">8</xref>]</td><td align="center" rowspan="1" colspan="1">2015</td><td align="center" rowspan="1" colspan="1">A 39-year-old Japanese man was found to have erythema on his right eyelid and right cheek in 2010</td><td align="center" rowspan="1" colspan="1">Anti-double-stranded DNA antigen, anti- SSA antigen, and anti-SBB antigen were all negative</td><td align="center" rowspan="1" colspan="1">Histopathology showed parakeratosis and hyperkeratosis of the horny layer and hydropic degeneration and vacuolar changes in the basal layer; the findings were consistent with DLE</td><td align="center" rowspan="1" colspan="1">Tacrolimus ointment was used with a good response</td></tr><tr><td align="left" colspan="6" rowspan="1"><hr></hr></td></tr><tr><td align="left" rowspan="1" colspan="1">Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis [<xref rid="B9" ref-type="bibr">9</xref>]</td><td align="center" rowspan="1" colspan="1">2005</td><td align="center" rowspan="1" colspan="1">A 33-year-old Caucasian man complaining of his lower eyelid for 8 months was diagnosed with discoid lupus</td><td align="center" rowspan="1" colspan="1">Antinuclear antibody was negative</td><td align="center" rowspan="1" colspan="1">Biopsy showed hyperkeratosis of the epithelium, thickened basement membrane, basal cell vacuolation, and dermal inflammation</td><td align="center" rowspan="1" colspan="1">6 weeks of hydroxychloroquine improved with 6 months follow-up</td></tr><tr><td align="left" colspan="6" rowspan="1"><hr></hr></td></tr><tr><td align="left" rowspan="1" colspan="1"> </td><td align="left" rowspan="1" colspan="1"> </td><td align="center" rowspan="1" colspan="1">A 58-year-old Caucasian woman presented with a complain of eyelid redness and thickening on the right side looks greater</td><td align="center" rowspan="1" colspan="1">Antinuclear antibody was negative</td><td align="center" rowspan="1" colspan="1">Biopsy results showed benign chronic inflammation in the dermis, hyperkeratosis of the epithelium, thickened basement membrane, basal cell vacuolation, and telangiectasias, which was consistent with discoid lupus</td><td align="center" rowspan="1" colspan="1">Treatment with hydroxychloroquine</td></tr><tr><td align="left" rowspan="1" colspan="1"> </td><td align="left" rowspan="1" colspan="1"> </td><td align="center" rowspan="1" colspan="1">A 54-year-old Caucasian woman presented with 25 years of chronic inflammation and scarring of the eyelid and philtrum</td><td align="center" rowspan="1" colspan="1">Antinuclear antibodies were negative</td><td align="center" rowspan="1" colspan="1">Biopsy from the right lower eyelid showed epithelial atrophy, focal dyskeratosis, and a thickened basement membrane with an area of focal destruction</td><td align="center" rowspan="1" colspan="1">Treated with hydroxychloroquine 200 mg twice a day and showed marked improvement over 2 months</td></tr><tr><td align="left" colspan="6" rowspan="1"><hr></hr></td></tr><tr><td align="left" rowspan="1" colspan="1"> </td><td align="left" rowspan="1" colspan="1"> </td><td align="center" rowspan="1" colspan="1">A 41-year-old Caucasian woman presented with 2-year history of eyelid redness and conjunctival infection</td><td align="center" rowspan="1" colspan="1">Antinuclear antibodies were negative</td><td align="center" rowspan="1" colspan="1">Biopsy showed granular deposition of IgM, IgG, IgA, and C3 along with the dermo-epidermal junction which was consistent with DLE</td><td align="center" rowspan="1" colspan="1">Hydroxychloroquine 200 mg was bid orally and showed improvement over 2 weeks of treatment</td></tr><tr><td align="left" colspan="6" rowspan="1"><hr></hr></td></tr><tr><td align="left" rowspan="1" colspan="1">Discoid lupus erythematosus of the periorbital edema: clinical dilemmas and diagnostic delays [<xref rid="B10" ref-type="bibr">10</xref>]</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">A 50-year-old Caucasian woman presented with a complain of painless and slowly progressive right periorbital swelling</td><td align="center" rowspan="1" colspan="1">The article did not mention the serology study</td><td align="center" rowspan="1" colspan="1">Biopsy showed perivascular lymphocytic infiltrate throughout the dermis and the basal epidermal layer, with florid lichenoid changes and vacuolar degeneration which were consistent with DLE</td><td align="center" rowspan="1" colspan="1">Oral corticosteroid was started, with improvement noticed over 12 months</td></tr><tr><td align="left" colspan="6" rowspan="1"><hr></hr></td></tr><tr><td align="left" rowspan="1" colspan="1"> </td><td align="left" rowspan="1" colspan="1"> </td><td align="center" rowspan="1" colspan="1">A 48-year-old Afro-Caribbean female complains of blepharitis with a demarcated area of depigmentation of both lower lid margins</td><td align="left" rowspan="1" colspan="1"> </td><td align="center" rowspan="1" colspan="1">Biopsy showed chronic inflammation which was consistent with DLE</td><td align="center" rowspan="1" colspan="1">The patient was treated with hydroxychloroquine with good response</td></tr><tr><td align="left" colspan="6" rowspan="1"><hr></hr></td></tr><tr><td align="left" rowspan="1" colspan="1"> </td><td align="left" rowspan="1" colspan="1"> </td><td align="center" rowspan="1" colspan="1">A 23-year-old Afro-Caribbean male complains of persistent right lower lid swelling</td><td align="left" rowspan="1" colspan="1"> </td><td align="center" rowspan="1" colspan="1">Biopsy showed features that confirmed DLE</td><td align="center" rowspan="1" colspan="1">The patient was started on hydroxychloroquine, but due to poor compliance there was no response</td></tr><tr><td align="left" colspan="6" rowspan="1"><hr></hr></td></tr><tr><td align="left" rowspan="1" colspan="1">Eyelid discoid lupus erythematosus and contact dermatitis: a case report [<xref rid="B11" ref-type="bibr">11</xref>]</td><td align="center" rowspan="1" colspan="1">2004</td><td align="center" rowspan="1" colspan="1">A 71-year-old white female complains of watery eyelids with itching and redness for 10 years</td><td align="center" rowspan="1" colspan="1">Antinuclear antibodies, anti-DNA, anti-Sm, anti-RNP, anticardiolipin, SS-A (Ro), and SS-B (La) were all negative</td><td align="center" rowspan="1" colspan="1">Biopsy showed basal cell vacuolar alteration. Showed IgA, IgG, IgM, and C3 intense granular deposits in a band-like pattern along the dermalepidermal junction</td><td align="center" rowspan="1" colspan="1">Treatment with chloroquine 250 mg/day for 3 months. But this was stopped due to side effects and treatment was changed to corticosteroid</td></tr><tr><td align="left" colspan="6" rowspan="1"><hr></hr></td></tr><tr><td align="left" rowspan="1" colspan="1">Periorbital edema and erythema: an unusual localization of DLE in a patient with psoriasis [<xref rid="B12" ref-type="bibr">12</xref>]</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">A 33-year-old woman presented with complain of malar erythema and left eye periorbital swelling for 2 years</td><td align="center" rowspan="1" colspan="1">Antinuclear antibodies and anti-DNA antibodies were negative</td><td align="center" rowspan="1" colspan="1">Biopsy showed vacuolar degeneration at the basal layer of the epidermis with mild hyperkeratosis. Perivascular lymphocytic infiltration and scattered melanophages on the upper dermis</td><td align="center" rowspan="1" colspan="1">Hydroxychloroquine 400 mg od po and topical corticosteroid</td></tr><tr><td align="left" colspan="6" rowspan="1"><hr></hr></td></tr><tr><td align="left" rowspan="1" colspan="1">Severe chronic blepharitis and scarring ectropion associated with discoid lupus erythematosus [<xref rid="B13" ref-type="bibr">13</xref>]</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">A 45-year-old Caucasian woman presented with complain of eyelid redness and irritation for 21 years</td><td align="center" rowspan="1" colspan="1">Antinuclear antibodies were negative</td><td align="center" rowspan="1" colspan="1">Biopsy showed hyperkeratosis of the epithelium and a thick basement membrane and a sign of chronic inflammation which was consistent with DLE</td><td align="center" rowspan="1" colspan="1">The patient was started on hydroxychloroquine 200 mg bid po, with improvement noticed over 2 months</td></tr></tbody></table></table-wrap></floats-group></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000278 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000278 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:6778949
|texte= Systemic Lupus Erythematosus Presented with Bilateral Orbital Edema and Negative Serology
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:31662937" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |